The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...
New rules require drugmakers to be clearer about explaining the risks and side effects of prescription drugs. The new guidelines from the the Food and Drug Administration are designed to do away with ...